missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Rislenemdaz, MedChemExpress
Description
Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively.
Specifications
Specifications
| Kemiskt namn eller material | Rislenemdaz |
| Fysisk form | Solid |
| CAS | 808732-98-1 |
| Färg | White |
| Kvantitet | 5 mg |
| Anteckningar om renhetsgrad | Research |
| Molekylformel | C19H23FN4O2 |
| För användning med (applikation) | Neuroscience-Neurodegeneration |
| Synonym | MK-0657 CERC-301 |
| Löslighetsinformation | DMSO : 100 mg/mL (279.01 mM; Need ultrasonic) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?